Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

Details

Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications

FDA-2026-N-5816-0001Notice
Document

Details

The document's own metadata, straight from the source system.

Title
Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications
Posted
Jun 3, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗